Row
C
CYTKAI Stock Diagnostic Report
Cytokinetics EVP research & development sells $265,370 in stock
The Executive Vice President of R&D at Cytokinetics has sold shares of the company.
View Source Article ↗AI CATALYST SCORE35 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time